Results 71 to 80 of about 55,654 (235)
Fluconazole-resistant candidosis in an HIV cohort [PDF]
, 1994 Objectives: To report the occurrence of HIV-related mucosal candidosis that fails to respond to fluconazole, to establish the correlation between in vitro susceptibility testing and clinical failure, and to assess the efficacy of alternative treatments ...
Baily, Guy G. +3 more
core +1 more source
Future Journal of Pharmaceutical Sciences, 2023 Background Fluconazole, an antifungal drug, prevents fungi growth by inhibiting the formation of a protective covering. Ivermectin has several biological activities, such as antibacterial, antiviral, and anti-cancer characteristics, and offers various ...
Popat Mohite +5 more
doaj +1 more source
Organ Medicine, EarlyView.This retrospective study evaluated metagenomic next‑generation sequencing (mNGS) against conventional methods (India ink, culture, antigen) for diagnosing cryptococcal infection in 16 kidney transplant recipients. mNGS showed a significantly higher positivity rate (93.8% vs 62.5%, p = 0.031) and shorter turnaround time (24 vs. 120 h, p < 0.001).
Luhao Liu +6 more
wiley +1 more source
CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 523-539, March 2025.Abstract Ritonavir (RTV) is a potent CYP3A inhibitor that is widely used as a pharmacokinetic (PK) enhancer to increase exposure to select protease inhibitors. However, as a strong and complex perpetrator of CYP3A interactions, RTV can also enhance the exposure of other co‐administered CYP3A substrates, potentially causing toxicity.
Lien Thi Ngo +5 more
wiley +1 more source
Vaginal azoles versus oral fluconazole in treatment of recurrent vulvovaginal candidiasis [PDF]
Background: Vulvovaginal candidiasis (VVC) is a fungal infection of the vagina and vulva. It is usually caused by Candida albicans, however, occasionally other candida species are responsible. The optimal treatment of VVC has not yet been defined.
فردی آذر, زهرا +3 more
core
The assessment of therapeutic response of oropharyngeal and oesophageal candidiasis in AIDS using a new scoring system: studies with D0870. [PDF]
, 1999 We developed and compared five scoring systems designed to quantitate therapeutic response in cases of oropharyngeal candidiasis. We utilized prospectively collected data on 114 patients treated with several doses of the azole D0870.
Williams, Keith +7 more
core
Fluconazole use as an important risk factor in the emergence of fluconazole-resistant Candida glabrata fungemia [PDF]
, 2009 Fluconazole use as an important risk factor in the emergence of fluconazole-resistant Candida glabrata ...
Tumbarello, Mario +3 more
core +1 more source
Fluconazole and Ibuprofen Combination: A Potential Treatment for Mucosal Candidiasis
Medical Laboratory Journal, 2020 Background and objectives: The incidence of drug-resistant candidiasis has increased dramatically. This study aimed to evaluate antifungal effects of fluconazole alone and in combination with ibuprofen on isolates from patients with mucosal candidiasis.
Tahere Shamoushaki, Leila Fozouni
doaj
Treatment of discospondylitis in dogs: A systematic review
Veterinary Record, EarlyView.Abstract Background Both medical and surgical techniques have been reported to manage canine discospondylitis, although data on clinical effectiveness and long‐term prognosis remain limited. Methods A systematic review of studies on treatment approaches, follow‐up data and investigation methods was conducted.
Vasileios Ioannis Vallios +4 more
wiley +1 more source
Profile of Candida Resistancy to Fluconazole in Male Patient with Oral Candidiasis and HIV/AIDS [PDF]
, 2019 Background: Oral candidiasis is one of the most common opportunistic infections found in patients with Human Immunodeficiency Virus (HIV)/Acquired immune deficiency syndrome (AIDS). The number of HIV/AIDS patient increases every years.
Dwi Murtiastutik +2 more
core